Citalopram for Sx/Util in Acute Coronary Syndrome Patients
Status:
Withdrawn
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
Symptoms (chest pain, shortness of breath, dizziness, etc.) and treatment usage (doctor or
emergency room visits, testing, hospital days, etc.) in patients with Acute Coronary
Syndromes are known to be related to emotional distress (Anxiety, Depression and Anger). In
addition, behavioral treatment of emotional distress is known to decrease symptoms, and
treatment usage. The present protocol tests whether the addition of a medication known to
reduce emotional distress can also reduce symptoms and treatment usage.
This will done by recruiting patients with ACS during their hospital stay, randomizing them
to receive citalopram or placebo, and then examining their symptoms and treatment usage at 6
months.